Department of Paediatrics, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, 100053 Beijing, China.
Clinical Medical School, Beijing University of Chinese Medicine, 100029 Beijing, China.
J Integr Neurosci. 2024 Jan 22;23(1):20. doi: 10.31083/j.jin2301020.
More than half of the patients with autism spectrum disorder (ASD) have gastrointestinal (GI) comorbidities, such as constipation, indigestion, abdominal pain, and diarrhea. Recent studies suggest prescribing probiotics and prebiotics in ASD could relieve GI disturbances and behavioral issues. This narrative review generalizes the research progress on probiotic and prebiotic therapies for ASD over the past 5 years and further discusses the underlying mechanisms of interaction between probiotics and prebiotics with ASD. Preliminary evidence has demonstrated the beneficial effects of probiotics and prebiotics on GI problems, autism-related behavioral disorders, and gut microbiome composition; the mechanism of probiotics and prebiotics in the treatment of ASD is mediated through inflammatory signaling pathways, metabolic pathways, neuronal signaling pathways, and the involvement of the vagus nerve. However, the results are inconclusive and mainly generated by animal experiments. Overall, the present review recommends further standardization of clinical studies to draw more robust evidence for prescribing probiotics and prebiotics in ASD.
超过一半的自闭症谱系障碍(ASD)患者存在胃肠道(GI)共病,如便秘、消化不良、腹痛和腹泻。最近的研究表明,在 ASD 中使用益生菌和益生元可以缓解胃肠道紊乱和行为问题。本综述概括了过去 5 年中关于益生菌和益生元治疗 ASD 的研究进展,并进一步讨论了益生菌和益生元与 ASD 相互作用的潜在机制。初步证据表明益生菌和益生元对胃肠道问题、自闭症相关行为障碍和肠道微生物组组成具有有益作用;益生菌和益生元治疗 ASD 的机制是通过炎症信号通路、代谢途径、神经元信号通路和迷走神经的参与来介导的。然而,结果并不确定,主要是由动物实验产生的。总的来说,本综述建议进一步规范临床研究,为 ASD 中使用益生菌和益生元提供更有力的证据。